229 related articles for article (PubMed ID: 29740203)
1. Olfactomedin-4 in digestive diseases: A mini-review.
Wang XY; Chen SH; Zhang YN; Xu CF
World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
[TBL] [Abstract][Full Text] [Related]
2. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
Liu W; Rodgers GP
Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
[TBL] [Abstract][Full Text] [Related]
3. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
Liu W; Yan M; Liu Y; Wang R; Li C; Deng C; Singh A; Coleman WG; Rodgers GP
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11056-61. PubMed ID: 20534456
[TBL] [Abstract][Full Text] [Related]
4. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
Yu L; Wang L; Chen S
Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260
[TBL] [Abstract][Full Text] [Related]
5. Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.
Li H; Liu W; Chen W; Zhu J; Deng CX; Rodgers GP
Sci Rep; 2015 Nov; 5():16974. PubMed ID: 26581960
[TBL] [Abstract][Full Text] [Related]
6. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling.
Guo LL; He ZC; Yang CQ; Qiao PT; Yin GL
BMB Rep; 2015 Nov; 48(11):630-5. PubMed ID: 26303970
[TBL] [Abstract][Full Text] [Related]
8. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
Jang BG; Lee BL; Kim WH
Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
[TBL] [Abstract][Full Text] [Related]
9. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
[TBL] [Abstract][Full Text] [Related]
10. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
[TBL] [Abstract][Full Text] [Related]
11. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
[TBL] [Abstract][Full Text] [Related]
12. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
14. Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells.
Liu RH; Yang MH; Xiang H; Bao LM; Yang HA; Yue LW; Jiang X; Ang N; Wu LY; Huang Y
J Biomed Sci; 2012 Apr; 19(1):38. PubMed ID: 22471589
[TBL] [Abstract][Full Text] [Related]
15. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
[TBL] [Abstract][Full Text] [Related]
16. Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades.
Klaas M; Mäemets-Allas K; Heinmäe E; Lagus H; Arak T; Eller M; Kingo K; Kankuri E; Jaks V
Cell Mol Life Sci; 2022 Feb; 79(3):157. PubMed ID: 35218417
[TBL] [Abstract][Full Text] [Related]
17. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells.
Kobayashi D; Koshida S; Moriai R; Tsuji N; Watanabe N
Cancer Sci; 2007 Mar; 98(3):334-40. PubMed ID: 17270022
[TBL] [Abstract][Full Text] [Related]
18. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor.
Chin KL; Aerbajinai W; Zhu J; Drew L; Chen L; Liu W; Rodgers GP
Br J Haematol; 2008 Nov; 143(3):421-32. PubMed ID: 18764868
[TBL] [Abstract][Full Text] [Related]
19. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ohkuma R; Yada E; Ishikawa S; Komura D; Ishizaki H; Tamada K; Kubota Y; Hamada K; Ishida H; Hirasawa Y; Ariizumi H; Satoh E; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Yokobori T; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Izumizaki M; Kobayashi S; Tsunoda T; Wada S
PLoS One; 2020; 15(1):e0226707. PubMed ID: 31923206
[TBL] [Abstract][Full Text] [Related]
20. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.
Luo Z; Zhang Q; Zhao Z; Li B; Chen J; Wang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1713-20. PubMed ID: 21904905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
